Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

NOW® Launches Calm & Focus with Zembrin® & GABA Dietary Supplement for Cognitive Support


News provided by

PLT Health Solutions

Nov 13, 2023, 08:40 ET

Share this article

Share toX

Share this article

Share toX

Experiential Formula Helps Promote Alert Serenity, Calm Focus and Improved Mental Functioning

MORRISTOWN, N.J., Nov. 13, 2023 /PRNewswire/ -- PLT Health Solutions, Inc. announced NOW®, an award-winning innovator, formulator and supplier of high-quality supplement, functional food, personal care and pet health products, has introduced a new product targeted to providing cognitive support in an increasingly stressed-out world.* Called Calm & Focus with Zembrin & GABA, the formulation features the clinically demonstrated stress reducing, mood enhancing properties of Zembrin Sceletium tortuosum to offer consumers fast, effective cognitive support.* Zembrin® is a novel, patented, clinically studied extract of the South African succulent plant Sceletium tortuosum. Zembrin can help give people power over their lives by introducing a sense of calm serenity and alert focus.* It is an experiential ingredient that has been shown to start working in as little as 2 hours and is safe enough to be used every day for months.

Continue Reading
According to Kim Perkins, Vitamin Brand Manager for NOW, "The clinical science behind Zembrin shows that it can help give people power over their lives by introducing a sense of calm serenity or alert focus.* We also feel our customers will be intrigued by the fact that it is a highly sustainable and socially responsible ingredient. Calm & Focus with Zembrin & GABA features 25 mg of Zembrin and 300 mg of Gamma-Aminobutyric Acid - known as GABA.
According to Kim Perkins, Vitamin Brand Manager for NOW, "The clinical science behind Zembrin shows that it can help give people power over their lives by introducing a sense of calm serenity or alert focus.* We also feel our customers will be intrigued by the fact that it is a highly sustainable and socially responsible ingredient. Calm & Focus with Zembrin & GABA features 25 mg of Zembrin and 300 mg of Gamma-Aminobutyric Acid - known as GABA.
Zembrin innovator, HG&H Pharmaceuticals employs a seed-to-shelf ingredient management program with its specially cultivated Sceletium tortuosum raw materials. They formally acknowledge and reward the contribution of the Khoi-San people who had discovered and used the South African plant Sceletium for millennia. Zembrin is endorsed by the South African San Council.
Zembrin innovator, HG&H Pharmaceuticals employs a seed-to-shelf ingredient management program with its specially cultivated Sceletium tortuosum raw materials. They formally acknowledge and reward the contribution of the Khoi-San people who had discovered and used the South African plant Sceletium for millennia. Zembrin is endorsed by the South African San Council.

According to Kim Perkins, Vitamin Brand Manager for NOW, people are increasingly reaching for cognitive support to confront the rigors of the modern-day world. "The clinical science behind Zembrin shows that it can help give people power over their lives by introducing a sense of calm serenity or alert focus," she said. * We also feel our customers will be intrigued by the fact that it is a highly sustainable and socially responsible ingredient. Calm & Focus with Zembrin & GABA features 25 mg of Zembrin and 300 mg of Gamma-Aminobutyric Acid – known as GABA – which is an amino acid that is known to reduce the stress of everyday life, relieve tension and improve sleep.*

An ancient remedy improved by modern science

Zembrin is a novel, patented, clinically studied, and commercially successful extract of the South African succulent plant Sceletium tortuosum. Sceletium has been used as a mood enhancer and stress reliever by the Khoi-San of South Africa, referred to as the world's first people, with a culture that stretches back over 20,000 years. Zembrin has an extensive and forward-thinking clinical science program and has been the subject of a broad range of pre-clinical work, a full array of safety and toxicity evaluations and five gold standard clinical trials published in peer-reviewed scientific journals. Studies have shown that a 25 mg per day dose of Zembrin can reduce anxiety-related activity within two hours of administration.*

A sustainable, socially responsible ingredient

Sceletium tortuosum is a protected species in Africa and wild harvesting is not sustainable for commercial products. Zembrin innovator, HG&H Pharmaceuticals employs a seed-to-shelf ingredient management program with its specially cultivated Sceletium tortuosum raw materials. The company is committed to using only cultivated plant material to avoid depleting threatened wild plant stocks and to ensure consistent product quality.

HG&H Pharmaceuticals is determined to formally acknowledge and reward the contribution of the Khoi-San people who had discovered and used the South African plant Sceletium for millennia. Zembrin is endorsed by the South African San Council, with the exclusive use of their trademark for a Sceletium product. The San Council shares in the proceeds from the sale of every bottle of Zembrin. 

According to Steve Fink, Vice President of Marketing for PLT Health solutions, NOW's choice of Zembrin shows the company is committed to improving people's health in socially conscious way. "Zembrin sits at the nexus of traditional ethnobotany, modern science, sustainability, and social responsibility and is a model of how a traditional plant can be transformed into a modern nutraceutical ingredient to help people live happier, healthier lives," he said. "We're excited to partner with NOW and for the help this product will bring to their customers," he added.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

About NOW®

Founded by Elwood Richard in 1968 on the belief that natural is better, NOW has grown from a small family operation into one of the most highly respected manufacturers in the natural products industry. Still a family-owned company today, NOW® provides customers with a comprehensive approach to wellness by offering more than 1,400 dietary supplements, functional foods, sports nutrition and health and beauty products. NOW is committed to offering safe, affordable products of the highest quality, and is a highly regarded advocate in the natural products industry. After 55 years in the natural products industry, NOW® remains committed to its original mission – to provide value in products and services that empower people to lead healthier lives. For more information, visit NOWFoods.com.

About PLT Health Solutions

Headquartered in Morristown, NJ, USA, PLT Health Solutions is a trusted discoverer, developer, and marketer of high-quality, scientifically supported ingredients that enhance health and functionality. PLT's global network of strategic partnerships provides unique access to impactful solutions. PLT Health Solutions is a purpose-driven company passionate about helping people live healthier, happier lives. By delivering an unsurpassed mix of expertise, resources, and service, PLT is committed to helping both its strategic partners and valued customers grow.

Media Contact:

Company Contact:                   

NOW Trade Media Contact:

Mark Falconer  

Steve Fink                                 

Suzanne Shelton

Sciencewerks                                 

PLT Health Solutions, Inc.     

The Shelton Group

E-mail: [email protected]       

E-mail: [email protected]

Voice: 847-922-4343



E-mail: [email protected]

SOURCE PLT Health Solutions

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

PLT Releases New Consumer Research on the Effects of 'Mood' in the Sports and Active Nutrition Category

PLT Releases New Consumer Research on the Effects of 'Mood' in the Sports and Active Nutrition Category

PLT Health Solutions, Inc today announced the release of new consumer research on how cognitive states – or mood – affect their sports and active...

PLT Wants Attendees to 'Feel the Science' with Disruptive Beverage-Friendly Ingredients at IFT First 2025

PLT Wants Attendees to 'Feel the Science' with Disruptive Beverage-Friendly Ingredients at IFT First 2025

At this year's IFT First Conference in Chicago, IL USA, PLT Health Solutions, Inc. will be highlighting its growing portfolio of 'beverage-friendly'...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Supplementary Medicine

Supplementary Medicine

Fitness/Wellness

Fitness/Wellness

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.